Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed‐up Study) - Concepedia

Concepedia

Publication | Open Access

Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed‐up Study)

DOI Full Paper Access

26

Citations

23

References

2022

Year

Anat Yerushalmy‐Feler, Gemma Pujol‐Muncunill, Javier Martin‐de‐carpi, Kaija‐Leena Kolho, Arie Levine, Christine Olbjørn, Maya Granot, Matteo Bramuzzo, Helena Rolandsdotter, Natalia Mouratidou,

Journal of Pediatric Gastroenterology and Nutrition

Abstract

Two-thirds of children with active CD responded to dose escalation of UST. Milder disease activity may predict a favorable outcome following UST dose escalation.

References

	Year	Citations

Page 1